Machine Learning: Lighting up protein design
Protein engineering is a growing area of research in which scientists use a variety of methods to design new proteins that can perform certain functions. For instance, enzymes that can biodegrade plastics, materials inspired by spider silk, or antibodies to neutralize viruses (Lu et al., 2022; Shan et al., 2022).
In the past, protein engineering has commonly relied on directed evolution, a laboratory procedure that mimics natural selection. This involves randomly mutating the genetic sequence of a naturally occurring protein to create multiple variants with slightly different amino acids. Various selection pressures are then applied to identify the ‘fittest’ variants that best carry out the desired role (Chen et al., 2018). Alternatively, researchers can use a rational design approach, in which new proteins are built using principles learned from the study of known protein structures (Anishchenko et al., 2021).
Now, in eLife, Fyodor A Kondrashov (from the Institute of Science and Technology Austria and the Okinawa Institute of Science and Technology Graduate University) and colleagues – including Louisa Gonzalez Somermeyer as first author – have combined elements of both approaches to engineer new variants of naturally occurring green fluorescent proteins (GFP; Gonzalez Somermeyer et al., 2022). First, the team (who are based at various institutes in Austria, Japan, the United States, the United Kingdom, Germany and Russia) generated tens of thousands of GFP variants that differed from each other by three to four mutations on average, and measured their fluorescence. This was used to create a ‘fitness landscape’ showing how the genetic sequence of each mutant relates to its performance (Figure 1). The data was then fed in to a neural network that can expand the landscape by predicting the performance of variants that were not observed experimentally.
Using this machine learning approach, Gonzalez Somermeyer et al. were able to design fluorescent proteins that differed from their closest natural relative by as many as 48 mutations. This is remarkable because in most protein mutagenesis experiments it only takes a few mutations before the function of the protein deteriorates. Evolution, on the other hand, can generate functional variants that differ by hundreds of mutations through a process of trial and error, which is akin to walking along a narrow ridge of high fitness one mutational step at a time. The neural network, however, appears to have jumped straight to a distant peak of high fitness (Figure 1). So, how did the network know where to take a leap?
To answer this, Gonzalez Somermeyer et al. experimented with three GFP proteins that originated from evolutionarily distant species. They found that machine learning was better at generating functional variants of cgreGFP than its two homologues, amacGFP and ppluGFP2 (a fourth homologue, avGFP, was also studied, but not in the machine learning experiment). This allowed the team to look for properties within each protein’s genetic sequence and fitness landscape which correlated with its machine learning performance.
Analysis of the fitness landscape revealed that the homologues differed in the number of mutations they could tolerate: it took on average three to four mutations until the fluorescence of cgreGFP and avGFP deteriorated, but seven to eight mutations were needed to compromise the function of amacGFP and ppluGFP2. The proteins also differed in their general sturdiness: ppluGFP2 was stable when exposed to high temperatures, whereas the structure of cgreGFP was more sensitive to changes in temperature.
Finally, Gonzalez Somermeyer et al. found that the increased mutational sensitivity of avGFP and cgreGFP (and to a lesser degree ppluGFP2) was due to negative epistasis – that is, when an individual mutation is well tolerated, but has a negative effect on the protein’s function when combined with other mutations (Bershtein et al., 2006; Domingo et al., 2019). The reduced fluorescence of amacGFP, however, could be ascribed almost entirely to additive effects, with each mutation incrementally making the protein less functional.
In order to generate functional variants, the network needs an opportunity to learn which properties of the fitness landscape are relevant from the data provided. The findings of Gonzalez Somermeyer et al. suggest that to predict a protein’s function, the algorithm only requires data on the effects of single-site mutations and low-order epistasis (interactions between small sets of mutations). This is good news for the protein engineering field as it suggests that prior knowledge of high-order interactions between large sets of mutations is not needed for protein design. Furthermore, it explains why the neural network is better at generating new variants of cgreGFP, which has a sharp fitness peak and high prevalence of epistasis.
In sum, these experiments provide a successful case study in protein engineering. An interesting extension would be to analyse the three-dimensional structures of the variants using AlphaFold, an algorithm which can predict a protein’s structure based on its amino acid sequence (Jumper et al., 2021). This would reveal if data from AlphaFold improves the prediction of functional variants, and help to identify structural features that rendered some of the variants non-fluorescent despite them being predicted to work. In the near future, assessing a new variant’s structure before it is synthesized could become a standard validation step in the design of new proteins. Furthermore, studying the fitness landscapes of multiple related variants, as done by Gonzalez Somermeyer et al., could reveal how a protein’s genetic sequence and structure changed over the course of evolution (Hochberg and Thornton, 2017; Mascotti, 2022). A better understanding of the evolution of proteins will help scientists to engineer synthetic molecules that carry out specific roles.
References
-
The causes and consequences of genetic interactions (epistasis)Annual Review of Genomics and Human Genetics 20:433–460.https://doi.org/10.1146/annurev-genom-083118-014857
-
Reconstructing ancient proteins to understand the causes of structure and functionAnnual Review of Biophysics 46:247–269.https://doi.org/10.1146/annurev-biophys-070816-033631
-
Resurrecting enzymes by ancestral sequence reconstructionMethods in Molecular Biology 2397:111–136.https://doi.org/10.1007/978-1-0716-1826-4_7
Article and author information
Author details
Publication history
Copyright
© 2022, Kudla and Plech
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,686
- views
-
- 320
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cancer Biology
- Computational and Systems Biology
Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Timely and effective use of antimicrobial drugs can improve patient outcomes, as well as help safeguard against resistance development. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is currently routinely used in clinical diagnostics for rapid species identification. Mining additional data from said spectra in the form of antimicrobial resistance (AMR) profiles is, therefore, highly promising. Such AMR profiles could serve as a drop-in solution for drastically improving treatment efficiency, effectiveness, and costs. This study endeavors to develop the first machine learning models capable of predicting AMR profiles for the whole repertoire of species and drugs encountered in clinical microbiology. The resulting models can be interpreted as drug recommender systems for infectious diseases. We find that our dual-branch method delivers considerably higher performance compared to previous approaches. In addition, experiments show that the models can be efficiently fine-tuned to data from other clinical laboratories. MALDI-TOF-based AMR recommender systems can, hence, greatly extend the value of MALDI-TOF MS for clinical diagnostics. All code supporting this study is distributed on PyPI and is packaged at https://github.com/gdewael/maldi-nn.